The influence of first pass metabolism on the development and validation of an IVIVC for metoprolol extended release tablets

Author： Sirisuth N. Eddington N.D.

Publisher： Elsevier

ISSN： 0939-6411

Source： European Journal of Pharmaceutics and Biopharmaceutics, Vol.53, Iss.3, 2002-05, pp. : 301-309

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development and Validation of 'Level A' In Vitro - In Vivo Correlation for Extended Release Tablets of Lamotrigine

Current Bioactive Compounds, Vol. 12, Iss. 4, 2016-12 ,pp. : 289-296

Bentham Science Publishers

Access to resources Recommend Favorite

Tramadol Extended-Release Tablets

By Hair Philip I. Curran Monique P. Keam Susan J.

Drugs, Vol. 66, Iss. 15, 2006-01 ,pp. : 2017-2027

Adis International

Access to resources Recommend Favorite

Clinical development of metformin extended-release tablets for type 2 diabetes: an overview

By Schwartz Sherwin L Gordi Toufigh Hou Eddie Cramer Marilou Heritier Michelle Cowles Verne E

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 9, 2008-09 ,pp. : 1235-1243

Informa Healthcare

Access to resources Recommend Favorite

Development of Extended Zero-Order Release Gliclazide Tablets by Central Composite Design

By Vijayalakshmi P. Devi V. Kusum Narendra C. Srinagesh S.

Drug Development and Industrial Pharmacy, Vol. 34, Iss. 1, 2008-01 ,pp. : 33-45

Informa Healthcare

Access to resources Recommend Favorite

Development of Extended Release Divalproex Sodium Tablets Containing Hypdrophobic and Hydrophilic Matrix

Current Drug Delivery, Vol. 6, Iss. 3, 2009-07 ,pp. : 291-296

Bentham Science Publishers

Access to resources Recommend Favorite